Methods of using ultrasound waves for sonodynamic therapy
AssigneeAlpheus Medical, Inc.
InventorsVijay Agarwal, Braden Eliason, Jeremy Ling
Life of this patent
Estimating the term…
Abstract
Disclosed are methods of producing ultrasound waves for providing sonodynamic therapy. The method includes coupling a sonodynamic therapy device with an array of piezoelectric transducer elements to a skin surface. A controller is configured to generate an electrical drive signal to produce ultrasound waves to activate a sonosensitizer in a treatment region without damaging healthy cells in the treatment region.
Claims25
A method of producing ultrasound waves for sonodynamic therapy to treat tumor cells harboring a sonosensitizer, comprising:
- coupling a sonodynamic therapy device to a skin surface over a treatment region with the tumor cells of a patient, the sonodynamic therapy device comprising:
- an array of piezoelectric ultrasound transducer elements, wherein each of the piezoelectric ultrasound transducer elements comprises an emitting surface configured to emit an ultrasound wave,
- a controller, wherein the controller is coupled to the array of piezoelectric ultrasound transducer elements and the controller is configured to generate a plurality of signals for driving the piezoelectric ultrasound transducer elements and generating ultrasound waves, and
- a patient interface, wherein the patient interface is configured for conforming to the skin surface of the patient,
- driving the array of piezoelectric ultrasound transducer elements with the plurality of signals to activate the sonosensitizer in the treatment region of the patient,
- wherein the sonosensitizer comprises a porphyrin,
- wherein the plurality of signals comprises one or more frequencies in a range of 20 kHz to 2 MHz,
- wherein the plurality of signals comprises at least one selected from the group consisting of:
- a sine wave, a rectangular pulse, and a triangular pulse,
- wherein individual ones of the plurality of signals are configured to drive individual ones of the piezoelectric ultrasound transducer elements to emit the ultrasound waves to minimize a spatial variation of an acoustic intensity in the treatment region,
- wherein the controller uses an algorithm for the array of piezoelectric ultrasound transducer elements to provide the acoustic intensity in a range of 0.1 W/cm2 to 50 W/cm2,
- wherein the controller is configured to modulate the ultrasound waves with randomized phases, and
- wherein the patient interface comprises a cooling system placed between the array of piezoelectric ultrasound transducer elements and the treatment region, the cooling system comprising one or more cooling loops or channels and a flexible membrane configured to allow circulation of a coolant therein.
A method of producing ultrasound waves for sonodynamic therapy to treat tumor cells harboring a sonosensitizer, the method comprising:
- coupling a sonodynamic therapy device to a skin surface over a treatment region of a patient,
- wherein the sonodynamic therapy device comprises:
- a patient interface comprising a flexible membrane conforming to the skin surface of the patient and one or more cooling loops or channels,
- wherein the patient interface comprises at least one of a cap, a rigid shell, or a flexible shell,
- an array of piezoelectric ultrasound transducer elements, and
- a controller configured to generate a plurality of signals for driving the piezoelectric ultrasound transducer elements,
- wherein the controller drives the array of piezoelectric transducer elements at a plurality of frequencies in a range of 650 kHz to 2 MHz,
- wherein the controller uses an algorithm for the array of piezoelectric ultrasound transducer elements to provide an acoustic intensity in a range of 0.1 W/cm2 to 50 W/cm2,
- wherein the plurality of signals comprises at least one selected from the group consisting of:
- a sine wave, a rectangular pulse, and a triangular pulse,
- wherein each of the piezoelectric ultrasound transducer elements comprises an emitting surface configured to emit an ultrasound wave,
- driving the array of piezoelectric ultrasound transducer elements with the plurality of signals to activate the sonosensitizer in the treatment region,
- wherein the sonosensitizer comprises a porphyrin,
- circulating a coolant via the one or more cooling loops or channels,
- wherein individual ones of the plurality of signals are configured to drive individual ones of the piezoelectric ultrasound transducer elements to emit a plurality of ultrasound waves configured to minimize a spatial variation of the acoustic intensity in the treatment region,
- wherein the plurality of signals comprise a modulated wave parameter configured to modulate the plurality of ultrasound waves with randomized phases thereby promoting broad coverage across the treatment region, and
- wherein the plurality of signals are modulated by a duty cycle modulated drive signal configured to produce a low temporal average acoustic intensity within the treatment region.
A method of producing ultrasound waves for sonodynamic therapy to treat tumor cells harboring a sonosensitizer, comprising:
- coupling a sonodynamic therapy device to a skin surface over a treatment region with the tumor cells of a patient, the sonodynamic therapy device comprising:
- an array of piezoelectric ultrasound transducer elements, wherein each of the piezoelectric ultrasound transducer elements comprises an emitting surface configured to emit an ultrasound wave,
- a controller, wherein the controller is coupled to the array of piezoelectric ultrasound transducer elements and the controller is configured to generate a plurality of signals for driving the piezoelectric ultrasound transducer elements and generating ultrasound waves, and
- a patient interface, wherein the patient interface is configured for conforming to the skin surface of the patient,
- driving the array of piezoelectric ultrasound transducer elements with the plurality of signals to activate the sonosensitizer in the treatment region of the patient,
- wherein the sonosensitizer comprises a porphyrin,
- wherein the plurality of signals comprises one or more frequencies in a range of 20 kHz to 2 MHz,
- wherein individual ones of the plurality of signals are configured to drive individual ones of the piezoelectric ultrasound transducer elements to emit the ultrasound waves to minimize a spatial variation of an acoustic intensity in the treatment region,
- wherein the plurality of signals is configured to drive each of the piezoelectric ultrasound transducer elements to produce high temporal peak acoustic intensities within the treatment region with a low temporal average acoustic intensity when activating the sonosensitizer,
- wherein the controller uses an algorithm for the array of piezoelectric ultrasound transducer elements to provide the acoustic intensity in a range of 0.1 W/cm2 to 50 W/cm2;
- wherein the controller is configured to modulate the ultrasound waves with randomized phases, and
- wherein the patient interface comprises a cooling system placed between the array of piezoelectric ultrasound transducer elements and the treatment region, the cooling system comprising one or more cooling loops or channels and a flexible membrane configured to allow circulation of a coolant therein.
A method of producing ultrasound waves for sonodynamic therapy to treat tumor cells harboring a sonosensitizer, the method comprising:
- coupling a sonodynamic therapy device to a skin surface over a treatment region of a patient,
- wherein the sonodynamic therapy device comprises:
- a patient interface comprising a flexible membrane conforming to the skin surface of the patient and one or more cooling loops or channels,
- wherein the patient interface comprises at least one of a cap, a rigid shell, or a flexible shell,
- an array of piezoelectric ultrasound transducer elements, and
- a controller configured to generate a plurality of signals for driving the piezoelectric ultrasound transducer elements,
- wherein the controller drives the array of piezoelectric transducer elements at a plurality of frequencies in a range of 650 kHz to 2 MHz,
- wherein the controller uses an algorithm for the array of piezoelectric ultrasound transducer elements to provide an acoustic intensity in a range of 0.1 W/cm2 to 50 W/cm2,
- wherein each of the piezoelectric ultrasound transducer elements comprises an emitting surface configured to emit an ultrasound wave,
- driving the array of piezoelectric ultrasound transducer elements with the plurality of signals to activate the sonosensitizer in the treatment region,
- wherein the sonosensitizer comprises a porphyrin,
- circulating a coolant via the one or more cooling loops or channels,
- wherein individual ones of the plurality of signals are configured to drive individual ones of the piezoelectric ultrasound transducer elements to emit a plurality of ultrasound waves configured to minimize a spatial variation of the acoustic intensity in the treatment region,
- wherein the plurality of signals comprise a modulated wave parameter configured to modulate the plurality of ultrasound waves with randomized phases thereby promoting broad coverage across the treatment region, and
- wherein the plurality of signals are modulated by a duty cycle modulated drive signal configured to produce high temporal peak acoustic intensities within the treatment region with a low temporal average acoustic intensity within the treatment region.
A method of producing ultrasound waves for sonodynamic therapy to treat tumor cells harboring a sonosensitizer, comprising:
- coupling a sonodynamic therapy device to a skin surface over a treatment region with the tumor cells of a patient, the sonodynamic therapy device comprising:
- an array of piezoelectric ultrasound transducer elements, wherein each of the piezoelectric ultrasound transducer elements comprises an emitting surface configured to emit an ultrasound wave,
- a controller, wherein the controller is coupled to the array of piezoelectric ultrasound transducer elements and the controller is configured to generate a plurality of signals for driving the piezoelectric ultrasound transducer elements and generating ultrasound waves, and
- a patient interface, wherein the patient interface is configured for conforming to the skin surface of the patient,
- driving the array of piezoelectric ultrasound transducer elements with the plurality of signals to activate the sonosensitizer in the treatment region of the patient,
- wherein the sonosensitizer comprises a porphyrin,
- wherein the plurality of signals comprises one or more frequencies in a range of 20 kHz to 2 MHz,
- wherein individual ones of the plurality of signals are configured to drive individual ones of the piezoelectric ultrasound transducer elements to emit the ultrasound waves to minimize a spatial variation of an acoustic intensity in the treatment region,
- wherein the controller uses an algorithm for the array of piezoelectric ultrasound transducer elements to provide the acoustic intensity in a range of 0.1 W/cm2 to 50 W/cm2;
- wherein the controller uses at least one in situ variable selected from the group consisting of:
- a tissue depth, a tissue volume, a skull thickness, and a temperature, and generates the ultrasound waves based on the at least one in situ variable,
- wherein the controller is configured to modulate the ultrasound waves with randomized phases, and
- wherein the patient interface comprises a cooling system placed between the array of piezoelectric ultrasound transducer elements and the treatment region, the cooling system comprising one or more cooling loops or channels and a flexible membrane configured to allow circulation of a coolant therein.
A method of producing ultrasound waves for sonodynamic therapy to treat tumor cells harboring a sonosensitizer, the method comprising:
- coupling a sonodynamic therapy device to a skin surface over a treatment region of a patient,
- wherein the sonodynamic therapy device comprises:
- a patient interface comprising a flexible membrane conforming to the skin surface of the patient and one or more cooling loops or channels,
- wherein the patient interface comprises at least one of a cap, a rigid shell, or a flexible shell,
- an array of piezoelectric ultrasound transducer elements, and
- a controller configured to generate a plurality of signals for driving the piezoelectric ultrasound transducer elements,
- wherein the controller drives the array of piezoelectric transducer elements at a plurality of frequencies in a range of 650 kHz to 2 MHz,
- wherein the controller uses an algorithm for the array of piezoelectric ultrasound transducer elements to provide an acoustic intensity in a range of 0.1 W/cm2 to 50 W/cm2,
- wherein the controller uses at least one in situ variable selected from the group consisting of:
- a tissue depth, a tissue volume, a skull thickness, and a temperature, and generates the ultrasound waves based on the at least one in situ variable,
- wherein each of the piezoelectric ultrasound transducer elements comprises an emitting surface configured to emit an ultrasound wave,
- driving the array of piezoelectric ultrasound transducer elements with the plurality of signals to activate the sonosensitizer in the treatment region,
- wherein the sonosensitizer comprises a porphyrin,
- circulating a coolant via the one or more cooling loops or channels,
- wherein individual ones of the plurality of signals are configured to drive individual ones of the piezoelectric ultrasound transducer elements to emit a plurality of ultrasound waves configured to minimize a spatial variation of the acoustic intensity in the treatment region,
- wherein the plurality of signals comprise a modulated wave parameter configured to modulate the plurality of ultrasound waves with randomized phases thereby promoting broad coverage across the treatment region, and
- wherein the plurality of signals are modulated by a duty cycle modulated drive signal configured to produce a low temporal average acoustic intensity within the treatment region.
A method of producing ultrasound waves for sonodynamic therapy to treat tumor cells harboring a sonosensitizer, comprising:
- coupling a sonodynamic therapy device to a skin surface over a treatment region with the tumor cells of a patient, the sonodynamic therapy device comprising:
- an array of piezoelectric ultrasound transducer elements, wherein each of the piezoelectric ultrasound transducer elements comprises an emitting surface configured to emit an ultrasound wave,
- a controller, wherein the controller is coupled to the array of piezoelectric ultrasound transducer elements and the controller is configured to generate a plurality of signals for driving the piezoelectric ultrasound transducer elements and generating ultrasound waves, and
- a patient interface, wherein the patient interface is configured for conforming to the skin surface of the patient,
- driving the array of piezoelectric ultrasound transducer elements with the plurality of signals to activate the sonosensitizer in the treatment region of the patient,
- wherein the sonosensitizer comprises a porphyrin,
- wherein the plurality of signals comprises one or more frequencies in a range of 20 kHz to 2 MHz,
- wherein individual ones of the plurality of signals are configured to drive individual ones of the piezoelectric ultrasound transducer elements to emit the ultrasound waves to minimize a spatial variation of an acoustic intensity in the treatment region,
- wherein the controller uses an algorithm for the array of piezoelectric ultrasound transducer elements to provide the acoustic intensity in a range of 0.1 W/cm2 to 50 W/cm2;
- wherein the controller is configured to modulate the ultrasound waves with randomized phases, and
- wherein the patient interface comprises a cooling system placed between the array of piezoelectric ultrasound transducer elements and the treatment region, the cooling system comprising one or more cooling loops or channels and a flexible membrane configured to allow circulation of a coolant therein,
- wherein the driving the array of piezoelectric ultrasound transducer elements occurs with the patient in a seated position on a chair.
A method of producing ultrasound waves for sonodynamic therapy to treat tumor cells harboring a sonosensitizer, the method comprising:
- coupling a sonodynamic therapy device to a skin surface over a treatment region of a patient,
- wherein the sonodynamic therapy device comprises:
- a patient interface comprising a flexible membrane conforming to the skin surface of the patient and one or more cooling loops or channels,
- wherein the patient interface comprises at least one of a cap, a rigid shell, or a flexible shell,
- an array of piezoelectric ultrasound transducer elements, and
- a controller configured to generate a plurality of signals for driving the piezoelectric ultrasound transducer elements,
- wherein the controller drives the array of piezoelectric transducer elements at a plurality of frequencies in a range of 650 kHz to 2 MHz,
- wherein the controller uses an algorithm for the array of piezoelectric ultrasound transducer elements to provide an acoustic intensity in a range of 0.1 W/cm2 to 50 W/cm2,
- wherein each of the piezoelectric ultrasound transducer elements comprises an emitting surface configured to emit an ultrasound wave,
- driving the array of piezoelectric ultrasound transducer elements with the plurality of signals to activate the sonosensitizer in the treatment region,
- wherein the sonosensitizer comprises a porphyrin,
- circulating a coolant via the one or more cooling loops or channels,
- wherein individual ones of the plurality of signals are configured to drive individual ones of the piezoelectric ultrasound transducer elements to emit a plurality of ultrasound waves configured to minimize a spatial variation of the acoustic intensity in the treatment region,
- wherein the plurality of signals comprise a modulated wave parameter configured to modulate the plurality of ultrasound waves with randomized phases thereby promoting broad coverage across the treatment region, and
- wherein the plurality of signals are modulated by a duty cycle modulated drive signal configured to produce a low temporal average acoustic intensity within the treatment region,
- wherein the driving the array of piezoelectric ultrasound transducer elements occurs with the patient in a seated position on a chair.
Dependencies are inferred from the claim text.